*S. aureus* remains a dangerous pathogen, causing a multitude of serious and sometimes life-threatening diseases around the globe. This is mostly due to widespread antibiotic resistance, which considerably complicates the treatment of *S. aureus* infections^[@R5]^. MRSA strains in particular represent a major problem for public health systems, as they combine resistance to methicillin and other β-lactam antibiotics with relatively minor fitness costs, resulting in high infiltration of hospital and community settings^[@R6]^. Remarkably, in the U.S., the estimated number of deaths due to MRSA infections exceeds that due to HIV/AIDS^[@R7]^. While molecular typing and genome sequencing have provided better insight into MRSA epidemiology in recent years^[@R8]^, we have a severe lack of knowledge regarding the mechanisms by which specific molecular determinants cause the spread and pathogenic success of MRSA clones.

Only a very limited number of MRSA clones, belonging to five clonal complexes, are responsible for the majority of MRSA infections worldwide^[@R1]^. Specific STs are characteristic for a given geographical location. In China, as in most Asian countries, ST239 is predominant^[@R9]^. Recently, genome sequencing of an ST239 strain revealed a novel gene of unknown function (SATW20_21850), which is present in only three of the 43 global ST239 strains that have been sequenced^[@R3],[@R4],[@R10]^, and absent from all other known *S. aureus* genomes^[@R3]^. Based on its amino acid sequence, which contains a signal peptide and an LPXTG surface-anchoring motif, this gene encodes a secreted, surface-anchored protein of 15 kDa in its processed form. It is located at the 3\' end region of a 127.2-kb ΦSPβ-like prophage, which lacks other virulence-associated genes^[@R3]^. There is no similarity of the surface protein to other proteins found in the NCBI databases except for the highly similar, ΦSPβ-encoded SesI of *S. epidermidis* RP62A^[@R11]^. We termed the gene *sasX* and showed that it is absent from other major global MRSA strains by analyzing a series of strains from divergent clonal and geographical backgrounds (**[Supplementary Spreadsheet 1](#SD2){ref-type="supplementary-material"}** online).

Prompted by the epidemiological connection of *sasX* to MRSA ST239, we here evaluated the hypothesis that *sasX* represents a key factor determining the spread of MRSA in China^[@R9]^. To that end, we determined ST distribution and frequency of *sasX-*positive clones among \> 800 randomly selected *S. aureus* isolates from patients with *S.aureus* infections at three large teaching hospitals located in eastern China between 2003 and 2011 (**[Fig. 1a](#F1){ref-type="fig"}**). The situation in China in terms of MRSA infection rate and dominance of the ST239/SCC*~mec~*-III (Brazil/Hungary) clone is largely characteristic of that in most other Asian countries except Japan and South Korea, and Australia^[@R9],[@R12]-[@R15]^. Accordingly, ST239 clones were also predominant among the isolates investigated in our study, with ST5 being the second most frequently isolated ST (**[Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}** online). Notably, the frequency of *sasX*-positive invasive *S. aureus* clones increased significantly from 2003 to 2011 (from 19% to 31%, *P* = 0.0026). Among MRSA isolates, the frequency of *sasX* increased from 21% to 39% (*P* = 0.0028), while the increase among methicillin-sensitive *S. aureus* (MSSA) was not significant (**[Fig. 1b](#F1){ref-type="fig"}**). Furthermore, *sasX* was almost exclusively found among ST239 strains in 2003-2005, while its frequency among isolates of several other STs considerably increased since then (increase from 5% to 28% of non-ST239 clones among *sasX*-positive *S. aureus* between 2003-2005 and 2009-2011, *P* = 0.0048; **[Fig. 1c](#F1){ref-type="fig"}**). Moreover, presence of *sasX* was extremely rare (only one positive clone among 169 tested) among a collection of community isolates from healthy individuals in the same areas (**[Supplementary Spreadsheet 1](#SD2){ref-type="supplementary-material"}** online), indicating that *sasX*-positive clones spread predominantly within the hospital setting. Finally, we did not detect ST239 clones among community isolates, indicating that this ST is linked to hospital infections. Analysis of genes surrounding *sasX* in randomly selected clones of different STs showed that the horizontal transfer of *sasX* always occurs linked to the ΦSPβ-like prophage with a conserved phage insertion site, although occasional deletions within the phage were observed (**[Supplementary Table 1](#SD1){ref-type="supplementary-material"}** online). Together, these findings demonstrate an epidemic wave of hospital-associated *sasX*-positive MRSA in China. Furthermore, they indicate events of horizontal gene transfer resulting in the spread of *sasX* from ST239 to other STs and a causative link between the presence of *sasX* and invasiveness.

To understand the link between *sasX* and infection, we set out to elucidate the biological role of *sasX*. We first demonstrated that the SasX protein is expressed at the *S. aureus* cell surface using immunofluorescence and immunoblot detection (**[Fig. 2a,b](#F2){ref-type="fig"}**). Surface proteins in *S. aureus* fulfill a variety of functions that include first and foremost adhesion to host tissue^[@R16]^. In particular, adhesion to nasal epithelial cells is of major importance for the colonization, spread and virulence potential of *S. aureus* strains, inasmuch as the nares are the predominant location of *S. aureus* colonization in the human body^[@R17]^ and there is an epidemiological link between nasal carriage and infection^[@R18]^. However, the molecular basis of nasal colonization is incompletely understood and there are only a few molecular factors of *S. aureus* that have been identified as potentially responsible for nasal colonization, such as teichoic acids^[@R19]^ and specific surface proteins^[@R20]-[@R22]^. To measure the impact of *sasX* on nasal colonization, we constructed isogenic *sasX* deletion mutants in representative (**[Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}** online) ST239 and ST5 strains. Adhesion of the *sasX* mutant strains to human nasal epithelial cells in vitro was significantly impaired compared to the wild-type strains, and restored in *sasX-*complemented mutant strains (**[Fig. 2c](#F2){ref-type="fig"}**). Furthermore, recombinant SasX protein blocked adhesion of *S. aureus* to human nasal epithelial cells (**[Fig. 2d](#F2){ref-type="fig"}**; **[Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}** online). Moreover, *sasX* had a significant impact on in-vivo nasal colonization in separate and competitive colonization models (**[Fig. 2e](#F2){ref-type="fig"}**). These data demonstrate that the SasX surface protein promotes nasal colonization.

In addition to facilitating adhesion to host tissue, *S. aureus* surface proteins may cause intercellular bacterial aggregation, a phenotype with multiple consequences, such as increased biofilm formation and immune evasion capacity^[@R23]-[@R25]^. Indeed, we found that *sasX* facilitated the formation of large bacterial aggregates (**[Fig. 3a](#F3){ref-type="fig"}; [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}** online) and promoted biofilm formation (**[Fig. 3b](#F3){ref-type="fig"}**). Interestingly, *sasX* also facilitated primary attachment to an abiotic surface (**[Fig. 3c](#F3){ref-type="fig"}**), which is in keeping with our finding that *sasX* expression was highest during early growth, and decreased afterwards (**[Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}** online). Moreover, phagocytosis of the wild-type strain by human neutrophils was significantly lower than that of the *sasX* mutant strain (**[Fig. 3d,f](#F3){ref-type="fig"}**). Accordingly, survival in human blood (**[Fig. 3e](#F3){ref-type="fig"}**) and lysis of human neutrophils as a sign of prolonged bacterial survival after phagocytosis (**[Fig. 3g](#F3){ref-type="fig"}**) were significantly increased in the wild-type strain compared to the *sasX* deletion mutant. Notably, these effects are most likely caused predominantly by the aggregation phenotype and not by a gene regulatory effect, as *sasX* did not impact expression of the *ica* genes encoding biofilm exopolysaccharide biosynthesis, the biofilm and virulence regulator *agr*^[@R26]^, or a series of cytolysins and other surface protein genes (**[Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}** online). Together, these data show that *sasX* facilitates intercellular aggregation, leading to a significant enhancement of *S. aureus* immune evasion mechanisms.

*S. aureus* most frequently causes skin and respiratory infections^[@R27]^. Correspondingly, these were also the most abundant types of infection detected in our study **([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}** online). Among infections caused by *sasX*-positive clones, respiratory and pleural-cavity infections as well as abscesses were most prominent (significant difference by type of infection, *P* = 0.0139, chi square test). Therefore, to determine whether *sasX* is a virulence factor during *S. aureus* infection, we selected to perform murine abscess and lung infection models. Mice infected with the wild-type strains developed abscesses that were significantly larger than those in mice infected with the *sasX* mutant strains (**[Fig. 4a](#F4){ref-type="fig"}**). Furthermore, microscopic evaluation showed increased infiltration of inflammatory cells in the abscesses caused by the wild-type strain (**[Fig. 4d](#F4){ref-type="fig"}**). Of note, the strong impact of *sasX* on abscess size is similar to that observed with potent *S. aureus* toxins such as α-toxin^[@R28]^ or phenol-soluble modulins^[@R29]^. In addition, lung wet weight/body weight ratios, degree of inflammation in the lung as assessed by tumor necrosis factor αconcentration, and histological examination showed that *sasX* is also a major factor influencing *S. aureus* pathogenesis in the lungs (**[Fig. 4b,c,e](#F4){ref-type="fig"}**). Thus, our data classify *sasX* as a key determinant of MRSA skin and lung infection.

In conclusion, we identified *sasX* as a critical factor promoting nasal colonization, immune evasion and virulence, and a probable main driving force of the Asian MRSA epidemic. Furthermore, our data provide strong support to the notion that acquisition of specific molecular determinants via horizontal gene transfer represents a major mechanism enhancing the pathogenic potential and epidemiological success of MRSA clones. Moreover, based on our data, it is to be expected that the frequency of *sasX* among Asian and international MRSA clones will increase further. We thus propose drug development or vaccination efforts aimed at SasX to prevent MRSA colonization and infection.

Methods {#S1}
=======

For additional procedures, see [Supplementary Methods (**Supplementary Methods** online)](#SD1){ref-type="supplementary-material"}.

Bacterial isolates {#S2}
------------------

807 *S. aureus* isolates were randomly selected from different inpatients with *S. aureus* infections at three different teaching hospitals in China: 100 each from 2004, 2007, and 2010 from Huashan Hospital, Fudan University, Shanghai; 107 from 2006-2008 and 79 from 2009-2010 from Shandong Provincial Hospital, Shandong University, Jinan; 104 from 2003-2005, 105 from 2006-2008 and 112 from 2009-2011 from the first affiliated hospital of Wenzhou Medical College, Wenzhou. 49 *S. aureus* isolates from nasal swabs among more than 500 healthy volunteers in Shanghai and 120 from nasal swabs among more than 1000 healthy volunteers in Wenzhou were also collected as part of a population-based community prevalence study. Characteristics of all isolates are listed in **[Supplementary Spreadsheet 1](#SD2){ref-type="supplementary-material"}** online. Bacteria were identified as staphylococci by classic microbiological methods: Gram\'s stain, catalase and coagulase activity on rabbit plasma. *S. aureus* strains were further categorized by biochemical characterization using the Api-Staph test (BioMérieux, Lyon, France). All strains and plasmids used in this study are listed in **[Supplementary Table 2](#SD1){ref-type="supplementary-material"}** online. All oligonucleotides used for cloning or polymerase chain reaction procedures are listed in **[Supplementary Table 3](#SD1){ref-type="supplementary-material"}** online.

Nasal colonization model {#S3}
------------------------

All animal work was approved by the ethics committee of Fudan University. Female ICR mice were used for the nasal colonization model (ten mice per group). All mice were six to eight weeks of age at the time of use and received drinking water containing penicillin at 100 μg ml^-1^. *S. aureus* strains were grown to mid-exponential growth phase, washed, and resuspended in sterile phosphate-buffered saline (PBS) at 10^7^ colony-forming units (CFU) per μl. Mice were anesthetized with isoflurane. The inoculum, which contained 10^8^ CFU in 10 μl of PBS or PBS alone, was pipetted slowly into the nares of the anesthetized mice without touching the nose with the pipette tip. Seven days after inoculation, ten mice per strain were euthanized and evaluated for nasal carriage of *S. aureus*. The nasal region was wiped externally with 70% ethanol, and the nasal tissue was homogenized in 0.5 ml of tryptic soy broth (TSB). The total number of *S. aureus* CFU per nose was assessed by plating 100 μl diluted nasal suspensions on TSB agar containing penicillin (100 μg ml^-1^).

For the competitive nasal colonization model, 15 mice per group were used. *S. aureus* ST239 (HS663) and its isogenic *sasX* deletion mutant were grown to mid-exponential growth phase, washed, and resuspended at equal CFUs in sterile PBS at a total of 2×10^6^ CFU per μl. The following steps were similar to above, except that bacteria isolated from the noses at day seven were plated on penicillin and penicillin/tetracycline plates to distinguish wild-type from mutant bacteria.

Lung infection model {#S4}
--------------------

Inoculation was performed as described for the colonization model, but with 10^9^ CFU per 20 μl. *S. aureus* cell suspensions were pipetted into the nares of the anesthetized mice (n=10 per group) without touching the nose. At 5 days after inoculation, mice were euthanized. The lungs from selected groups of animals were excised, washed with saline, and one lobe was fixed in 10% formalin (Sigma). Paraffin embedding and hematoxylin & eosin (HE) staining were performed as previously described^[@R30]^. The other lobe was homogenized in 0.5 ml of TSB; homogenized lung tissue and serum samples were used for TNF-α detection.

Skin abscess model {#S5}
------------------

Female outbred, immune-competent, hairless mice were used for the abscess model. All mice were between four and six weeks of age at the time of use. *S. aureus* strains were grown to mid-exponential phase, washed once with sterile PBS, then resuspended in PBS at 1 × 10^9^ CFU per 100 μl. Mice were anesthetized with isoflurane and inoculated with 100 μl PBS containing 10^9^ live *S. aureus* or saline alone in the right flank by subcutaneous injection. We examined test animals at 24-h intervals for a total of 10 d with a caliper. We applied length (L) and width (W) values to calculate the area of abscesses with the formula L × W. Abscesses as shown in [Fig. 4a](#F4){ref-type="fig"} developed into scarred lesions during the time of the experiment. The sizes of these lesions showed similar differences as the closed abscesses between the wild-type and *sasX* mutant groups and remained until the end point of the experiment (**[Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}** online). However, only the sizes of closed abscesses were measured. All animals were euthanized after completion of the entire procedure.
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![Spread of *sasX*-positive clones in China. (**a**) A total of 807 isolates from three teaching hospitals in eastern China were analyzed for ST, methicillin resistance, and presence of *sasX*. (**b**) Percentage of *sasX*-positive among MSSA and MRSA isolates. Statistical analysis is by chi square test of all MRSA isolates (average curve, shown in black). The P value including all (MRSA and MSSA) isolates is 0.0026. (**c**) Percent of *sasX*-positive isolates in STs other than ST239. Statistical analysis is by Fisher\'s exact test of all isolates (average curve, shown in black).](nihms-354003-f0001){#F1}

![The SasX surface protein facilitates nasal colonization. (**a**) Detection of SasX using anti-SasX polyclonal antiserum in an indirect immunofluorescence assay. (**b**) Immunoblot detection of SasX in different subcellular fractions. Black arrows point to the putative SasX protein. Note that surface proteins in this assay run higher than their predicted molecular weights in the processed forms, owing to the linkage to remaining peptidoglycan parts. W, whole cell preparation; S, surface protein fraction; C, cytoplasmic fraction; E, extracellular fraction. (**c**) Adherence of wild-type, isogenic *sasX* mutant, *sasX*-complemented, and control strains to human nasal epithelial cells in vitro. (**d**) Blocking of adherence to nasal epithelial cells by recombinant GST-SasX fusion protein. Purified GST protein alone and denatured GST-SasX fusion protein were used as controls. (**e**) Nasal colonization model. Female ICR mice (n=10 per group in the separate model; n=15 per group in the competition model) were inoculated intranasally with 10^7^ CFU of wild-type or isogenic *sasX* mutant strains and bacteria were counted in mice that were euthanized at seven days post inoculation. ST239 HS770 was used for the separate and ST239 HS663 for the competition model. Equal amounts of wild-type and deletion mutant bacteria were mixed for the competition model inoculum. Statistical analyses in (c-e) are by unpaired t-tests.](nihms-354003-f0002){#F2}

![SasX promotes bacterial aggregation and mechanisms of immune evasion. (**a**) Microscopic pictures of 16-h cultures of ST239 wild-type, isogenic *sasX* mutant, *sasX-*complemented, and control strains. (**b**) Biofilm formation. Cultures were grown for 24 h in microtiter plates. Afterwards, biofilms were measured using crystal violet staining. (**c**) Primary attachment. The experiment was performed as that shown in (b), but with only 1 h growth. (**d**) Phagocytosis assay. Phagocytosis by human neutrophils of ST239 or the isogenic *sasX* mutant strain was examined using microscopy (see panel f). (**e**) Survival in human blood at t=90 min. (**f**) Microscopical examination of phagocytosis. Slides were stained using a modified Wright-Giemsa stain. At t=90 min, lysed neutrophils were occasionally detected in the ST239 wild-type samples. The 90 min ST239 image shows such a lysed neutrophil with adherent *S. aureus* bacteria. (**g**) Neutrophil killing. Bacteria from mid-logarithmic growth phase were washed and incubated with human neutrophils at a 100:1 ratio. Neutrophil lysis was determined by measuring release of lactate dehydrogenase (LDH). Statistical analyses in (b-e, g) are by unpaired t-tests.](nihms-354003-f0003){#F3}

![SasX is a key virulence determinant during MRSA skin and lung infection. (**a,d**) Skin infection. Outbred, immune-competent, hairless mice were inoculated with 10^9^ CFU of the ST239 or ST5 wild-type and isogenic *sasX* mutant strains. (**b,c,e**) Lung infection. Female ICR mice were inoculated in the noses with 10^9^ CFU/20 μl of the ST239 or ST5 wild-type and isogenic *sasX* mutant strains. Mice were euthanized at day five post infection for subsequent analyses. (**a**) Skin infection model, developing abscess areas (see representative images on the right). Differences between corresponding wild-type and mutant abscess sizes were statistically significant at every time point (unpaired t-tests, *P* \< 0.05). (**b**) Lung infection model, lung wet weight/body weight ratios. (**c**) Lung infection model, concentration of tumor necrosis factor α (TNF-α) in lung tissue samples. (**d**) Skin infection model, hematoxylin/eosin (HE) stained tissue samples. (**e**) Lung infection model, HE stained tissue samples. Note increased number of infiltrating inflammatory cells in wild-type sample pictures in (d) and extensive inflammation accompanied by hemorrhagic infiltration and disruption of pulmonary architecture in wild-type sample pictures in (e). Statistical analyses in (b,c) are by unpaired t-tests.](nihms-354003-f0004){#F4}
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